Citation： 文天夫. 轉化切除是提高肝細胞癌切除率的重要途徑. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(2): 133-136. doi: 10.7507/1007-9424.201912003 Copy
Copyright ? the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. | Hermann RE, Lonsdale D. Chemotherapy, radiotherapy, and hepatic lobectomy for hepatoblastoma in an infant: report of a survival. Surgery, 1970, 68(2): 383-388. |
| 2. | Yu YQ, Tang ZY, Zhou XD, et al. Treatment of huge primary liver cancer in stages. Chin J Surg, 1983, 21: 92-93. |
| 3. | Chen H, Wu MC. Reoperative primary liver cancer. report of 28 cases. Chin Med J (Engl), 1987, 100(10): 795-799. |
| 4. | Shafer AD, Selinkoff PM. Preoperative irradiation and chemotherapy for initially unresectable hepatoblastoma. J Pediatr Surg, 1977, 12(6): 1001-1007. |
| 5. | Sitzmann JV, Order SE, Klein JL, et al. Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer. J Clin Oncol, 1987, 5(10): 1566-1573. |
| 6. | Tang ZY, Yu YQ, Ma ZC, et al. Conversion of surgically verified unresectable to resectable hepatocellular carcinoma-a report of 26 patients with subsequent resection. Chin J Cancer Res, 1989, 1: 41-47. |
| 7. | Tang ZY, Yu YQ, Zhou XD, et al. Cytoreduction and sequential resection: a hope for unresectable primary liver cancer. J Surg Oncol, 1991, 47(1): 27-31. |
| 8. | Yu YQ, Xu DB, Zhou XD, et al. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer, 1993, 71(1): 62-65. |
| 9. | Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg, 1997, 226(6): 688-703. |
| 10. | Lau WY, Ho SK, Yu SC, et al. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg, 2004, 240(2): 299-305. |
| 11. | Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery, 1990, 107(5): 521-527. |
| 12. | Hwang S, Lee SG, Ko GY, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg, 2009, 249(4): 608-616. |
| 13. | Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg, 2012, 255(3): 405-414. |
| 14. | Irtan S, Chopin-Laly X, Ronot M, et al. Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection. Liver Int, 2011, 31(5): 740-743. |
| 15. | Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 1999, 19(3): 329-338. |
| 16. | Honjo I, Suzuki T, Ozawa K, et al. Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg, 1975, 130(3): 296-302. |
| 17. | Kinoshita H, Sakai K, Hirohashi K, et al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg, 1986, 10(5): 803-808. |
| 18. | Shinkawa H, Takemura S, Tanaka S, et al. Portal vein embolization: history and current indications. Visc Med, 2017, 33(6): 414-417. |
| 19. | Guiu B, Chevallier P, Denys A, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol, 2016, 26(12): 4259-4267. |
| 20. | Guiu B, Quenet F, Escal L, et al. Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function. Eur Radiol, 2017, 27(8): 3343-3352. |
| 21. | 劉暢, 張曉赟, 金諶, 等. 肝靜脈系統栓堵術在第二階段根治性肝癌切除術中的應用. 中國普外基礎與臨床雜志, 2019, 26(7): 841-846. |
| 22. | 周儉, 王征, 孫健, 等. 聯合肝臟離斷和門靜脈結扎的二步肝切除術. 中華消化外科雜志, 2013, 12(7): 485-489. |
| 23. | 彭馳涵, 李川, 文天夫, 等. 原發性肝癌行 ALPPS 的適應證與禁忌證初探 (附 15 例報道). 中國普外基礎與臨床雜志, 2015, 22(10): 1183-1186. |
| 24. | Melandro F, Giovanardi F, Hassan R, et al. Minimally invasive approach in the setting of alpps procedure: a systematic review of the literature. J Gastrointest Surg, 2019, 23(9): 1917-1924. |
| 25. | Xiao L, Li JW, Zheng SG. Totally laparoscopic ALPPS in the treatment of cirrhotic hepatocellular carcinoma. Surg Endosc, 2015, 29(9): 2800-2801. |
| 26. | 張宇, 陳云飛, 路濤, 等. 全腹腔鏡前入路經肝后隧道繞肝帶結扎并門靜脈結扎的分期肝切除術治療肝硬變肝癌. 中國普外基礎與臨床雜志, 2015, 22(1): 70-75. |
| 27. | Donati M, Basile F, Oldhafer KJ. Laparoscopic step 1 ALPPS with microwave transection of the liver for Klatskin tumors: is it worthwhile? Hepatobiliary Pancreat Dis Int, 2018, 17(3): 278-279. |
| 28. | Edmondson MJ, Sodergren MH, Pucher PH, et al. Variations and adaptations of associated liver partition and portal vein ligation for staged hepatectomy (ALPPS): many routes to the summit. Surgery, 2016, 159(4): 1058-1072. |
| 29. | Wang Z, Peng Y, Hu J, et al. Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis b virus-related hepatocellular carcinoma: a single center study of 45 patients. Ann Surg, 2018, [Epub ahead of print]. |
| 30. | Peng C, Li C, Liu C, et al. The outcome of the HCC patients underwent ALPPS: retrospective study. Medicine (Baltimore), 2019, 98(38): e17182. |
| 31. | Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology, 1983, 148(2): 397-401. |
| 32. | 林貴, 顧瑨, 韓莘野, 等. 選擇性血管造影診斷原發性肝癌. 中華放射學雜志, 1979, 13(3): 129-132. |
| 33. | 林貴, 王述靜, 顧瑨, 等. 肝動脈栓塞治療原發性肝癌的初步報告. 中華放射學雜志, 1984, 18(4): 241-243. |
| 34. | Yao FY, Hirose R, LaBerge JM, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl, 2005, 11(12): 1505-1514. |
| 35. | Zorzi D, Abdalla EK, Pawlik TM, et al. Subtotal hepatectomy following neoadjuvant chemotherapy for a previously unresectable hepatocellular carcinoma. J Hepatobiliary Pancreat Surg, 2006, 13(4): 347-350. |
| 36. | 李川江, 周杰. 肝細胞肝癌經肝動脈化療栓塞聯合索拉非尼降期后二期切除的初步報告. 腹部外科, 2017, 30(4): 295-298, 301. |
| 37. | He M, Li Q, Zou R, et al. Sorafenib plus hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion: a randomized clinical trial. JAMA Oncol, 2019, 5(7): 953-960. |
| 38. | Hamaoka M, Kobayashi T, Kuroda S, et al. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: a retrospective cohort study. Int J Surg, 2017, 44: 223-228. |
| 39. | Ronot M, Cauchy F, Gregoli B, et al. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden. HPB (Oxford), 2016, 18(8): 684-690. |
| 40. | Piardi T, Memeo R, Renard Y, et al. Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature. Minerva Chir, 2016, 71(3): 192-200. |
| 41. | Wang Z, Peng Y, Sun Q, et al. Salvage transhepatic arterial embolization after failed stage Ⅰ ALPPS in a patient with a huge HCC with chronic liver disease: a case report. Int J Surg Case Rep, 2017, 39: 131-135. |
| 42. | Mahipal A, Tella SH, Kommalapati A, et al. Immunotherapy in hepatocellular carcinoma: is there a light at the end of the tunnel? Cancers (Basel), 2019, 11(8): E1078. |
| 43. | Lau WY, Lai EC. Salvage surgery following downstaging of unresectable hepatocellular carcinoma—a strategy to increase resectability. Ann Surg Oncol, 2007, 14(12): 3301-3309. |
| 44. | Wei X, Jiang Y, Zhang X, et al. Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study. J Clin Oncol, 2019, 37(24): 2141-2151. |
- 1. Hermann RE, Lonsdale D. Chemotherapy, radiotherapy, and hepatic lobectomy for hepatoblastoma in an infant: report of a survival. Surgery, 1970, 68(2): 383-388.
- 2. Yu YQ, Tang ZY, Zhou XD, et al. Treatment of huge primary liver cancer in stages. Chin J Surg, 1983, 21: 92-93.
- 3. Chen H, Wu MC. Reoperative primary liver cancer. report of 28 cases. Chin Med J (Engl), 1987, 100(10): 795-799.
- 4. Shafer AD, Selinkoff PM. Preoperative irradiation and chemotherapy for initially unresectable hepatoblastoma. J Pediatr Surg, 1977, 12(6): 1001-1007.
- 5. Sitzmann JV, Order SE, Klein JL, et al. Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer. J Clin Oncol, 1987, 5(10): 1566-1573.
- 6. Tang ZY, Yu YQ, Ma ZC, et al. Conversion of surgically verified unresectable to resectable hepatocellular carcinoma-a report of 26 patients with subsequent resection. Chin J Cancer Res, 1989, 1: 41-47.
- 7. Tang ZY, Yu YQ, Zhou XD, et al. Cytoreduction and sequential resection: a hope for unresectable primary liver cancer. J Surg Oncol, 1991, 47(1): 27-31.
- 8. Yu YQ, Xu DB, Zhou XD, et al. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer, 1993, 71(1): 62-65.
- 9. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg, 1997, 226(6): 688-703.
- 10. Lau WY, Ho SK, Yu SC, et al. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg, 2004, 240(2): 299-305.
- 11. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery, 1990, 107(5): 521-527.
- 12. Hwang S, Lee SG, Ko GY, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg, 2009, 249(4): 608-616.
- 13. Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg, 2012, 255(3): 405-414.
- 14. Irtan S, Chopin-Laly X, Ronot M, et al. Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection. Liver Int, 2011, 31(5): 740-743.
- 15. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 1999, 19(3): 329-338.
- 16. Honjo I, Suzuki T, Ozawa K, et al. Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg, 1975, 130(3): 296-302.
- 17. Kinoshita H, Sakai K, Hirohashi K, et al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg, 1986, 10(5): 803-808.
- 18. Shinkawa H, Takemura S, Tanaka S, et al. Portal vein embolization: history and current indications. Visc Med, 2017, 33(6): 414-417.
- 19. Guiu B, Chevallier P, Denys A, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol, 2016, 26(12): 4259-4267.
- 20. Guiu B, Quenet F, Escal L, et al. Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function. Eur Radiol, 2017, 27(8): 3343-3352.
- 21. 劉暢, 張曉赟, 金諶, 等. 肝靜脈系統栓堵術在第二階段根治性肝癌切除術中的應用. 中國普外基礎與臨床雜志, 2019, 26(7): 841-846.
- 22. 周儉, 王征, 孫健, 等. 聯合肝臟離斷和門靜脈結扎的二步肝切除術. 中華消化外科雜志, 2013, 12(7): 485-489.
- 23. 彭馳涵, 李川, 文天夫, 等. 原發性肝癌行 ALPPS 的適應證與禁忌證初探 (附 15 例報道). 中國普外基礎與臨床雜志, 2015, 22(10): 1183-1186.
- 24. Melandro F, Giovanardi F, Hassan R, et al. Minimally invasive approach in the setting of alpps procedure: a systematic review of the literature. J Gastrointest Surg, 2019, 23(9): 1917-1924.
- 25. Xiao L, Li JW, Zheng SG. Totally laparoscopic ALPPS in the treatment of cirrhotic hepatocellular carcinoma. Surg Endosc, 2015, 29(9): 2800-2801.
- 26. 張宇, 陳云飛, 路濤, 等. 全腹腔鏡前入路經肝后隧道繞肝帶結扎并門靜脈結扎的分期肝切除術治療肝硬變肝癌. 中國普外基礎與臨床雜志, 2015, 22(1): 70-75.
- 27. Donati M, Basile F, Oldhafer KJ. Laparoscopic step 1 ALPPS with microwave transection of the liver for Klatskin tumors: is it worthwhile? Hepatobiliary Pancreat Dis Int, 2018, 17(3): 278-279.
- 28. Edmondson MJ, Sodergren MH, Pucher PH, et al. Variations and adaptations of associated liver partition and portal vein ligation for staged hepatectomy (ALPPS): many routes to the summit. Surgery, 2016, 159(4): 1058-1072.
- 29. Wang Z, Peng Y, Hu J, et al. Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis b virus-related hepatocellular carcinoma: a single center study of 45 patients. Ann Surg, 2018, [Epub ahead of print].
- 30. Peng C, Li C, Liu C, et al. The outcome of the HCC patients underwent ALPPS: retrospective study. Medicine (Baltimore), 2019, 98(38): e17182.
- 31. Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology, 1983, 148(2): 397-401.
- 32. 林貴, 顧瑨, 韓莘野, 等. 選擇性血管造影診斷原發性肝癌. 中華放射學雜志, 1979, 13(3): 129-132.
- 33. 林貴, 王述靜, 顧瑨, 等. 肝動脈栓塞治療原發性肝癌的初步報告. 中華放射學雜志, 1984, 18(4): 241-243.
- 34. Yao FY, Hirose R, LaBerge JM, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl, 2005, 11(12): 1505-1514.
- 35. Zorzi D, Abdalla EK, Pawlik TM, et al. Subtotal hepatectomy following neoadjuvant chemotherapy for a previously unresectable hepatocellular carcinoma. J Hepatobiliary Pancreat Surg, 2006, 13(4): 347-350.
- 36. 李川江, 周杰. 肝細胞肝癌經肝動脈化療栓塞聯合索拉非尼降期后二期切除的初步報告. 腹部外科, 2017, 30(4): 295-298, 301.
- 37. He M, Li Q, Zou R, et al. Sorafenib plus hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion: a randomized clinical trial. JAMA Oncol, 2019, 5(7): 953-960.
- 38. Hamaoka M, Kobayashi T, Kuroda S, et al. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: a retrospective cohort study. Int J Surg, 2017, 44: 223-228.
- 39. Ronot M, Cauchy F, Gregoli B, et al. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden. HPB (Oxford), 2016, 18(8): 684-690.
- 40. Piardi T, Memeo R, Renard Y, et al. Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature. Minerva Chir, 2016, 71(3): 192-200.
- 41. Wang Z, Peng Y, Sun Q, et al. Salvage transhepatic arterial embolization after failed stage Ⅰ ALPPS in a patient with a huge HCC with chronic liver disease: a case report. Int J Surg Case Rep, 2017, 39: 131-135.
- 42. Mahipal A, Tella SH, Kommalapati A, et al. Immunotherapy in hepatocellular carcinoma: is there a light at the end of the tunnel? Cancers (Basel), 2019, 11(8): E1078.
- 43. Lau WY, Lai EC. Salvage surgery following downstaging of unresectable hepatocellular carcinoma—a strategy to increase resectability. Ann Surg Oncol, 2007, 14(12): 3301-3309.
- 44. Wei X, Jiang Y, Zhang X, et al. Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study. J Clin Oncol, 2019, 37(24): 2141-2151.